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Background. An important step in the analysis of positron emission tomography (PET) studies of the brain is the definition
of regions of interest (ROI). Image coregistration, ROI analysis, and quantification of brain PET data in small animals can be
observer dependent. The purpose of this study was to investigate the feasibility of ROI analysis based on a standard MR template
and an additional [18F]NaF scan. Methods. [18F]NaF scans of 10 Wistar rats were coregistered with a standard MR template by
3 observers and derived transformation matrices were applied to corresponding [11C]AF150(S) images. Uptake measures were
derived for several brain regions delineated using the MR template. Overall agreement between the 3 observers was assessed
by interclass correlation coeﬃcients (ICC) of uptake data. In addition, [11C]AF150(S) ROI data were compared with ex vivo
biodistribution data. Results. For all brain regions, ICC analysis showed excellent agreement between observers. Reproducibility,
estimated by calculation of standard deviation of the between-observer diﬀerences, was demonstrated by an average of 17%
expressed as coeﬃcient of variation. Uptake of [11C]AF150(S) derived from ROI analysis closely matched ex vivo biodistribution
data. Conclusions. The proposed method provides a reproducible and tracer-independent method for ROI analysis of rat brain
PET data.
1. Introduction
An important step in the analysis of positron emission
tomography (PET) data is the definition of regions of interest
(ROI). For brain studies in man and large mammals, like
primates and pigs, it becomes more common practice to
use magnetic-resonance- (MR-) based templates [1–4]. For
brain studies in small animals, for example, rats, several
methods to define ROI have been proposed, for example,
spatial normalization to an MR brain atlas [5], predefined
PET templates [6, 7], direct ROI definition on PET images
[8], ROI definition using a coregistered segmented rat
brain atlas (based on autoradiography) [9], and probabilistic
atlases based on PET data (e.g., [18F]FDG, [18F]FECT,
and [11C]raclopride) for voxel-based functional mapping
[10].
In case of small animals, automated image coregistration
of PET data withMR templates is diﬃcult, because of the rel-
atively large diﬀerence in spatial resolution between MR and
PET. In this study, small animal imaging was performed on
a high-resolution PET scanner (i.e., ECAT high-resolution
research tomograph, HRRT) with a spatial resolution of 2.5
to 3mm and an MR scanner with a spatial resolution of
0.1mm, resulting in an MR to PET diﬀerence of at least
25 in one direction, and 253 in all directions. Furthermore,
MR-PET coregistration techniques require a certain level of
morphological correspondence between both images, that is,
there should be suﬃcient mutual information in both types
of images to allow automatic coregistration. Consequently,
characterization of new PET tracers with highly specific
uptake patterns can hamper direct coregistration of an MR
template to a PET image, either manually or automatically.
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A possible way to obtain anatomical information is to
perform an additional [18F]NaF scan, which can be acquired
immediately following an experimental PET study and which
can then be used for coregistration to the MR template.
As experiments are performed under anaesthesia and head
fixation device, an implicit registration between both PET
data sets can be assumed. [18F]NaF scans provide anatomical
(skull) information, as uptake of [18F]NaF in bone is high
with much lower uptake in brain tissue [11–13]. The outline
of the skull in an [18F]NaF scan provides an image that,
indirectly, is also available from an MR scan, where the
skull can be visualized by inverting the image colour scale
and setting this scale to maximum intensity. This provides
a two-step method for MR-based ROI analysis of PET
images in rat brains. The purpose of the present study
was to investigate the reproducibility of MR-based ROI
analysis using a standard MR template, coregistered with an
additionally acquired [18F]NaF scan. This method was tested
using [11C]AF150(S) in the rat brain [14]. [11C]AF150(S)
is a functionally selective agonist radioligand with moder-
ate aﬃnity for the muscarinic acetylcholine receptor M1
(M1ACh-R) in vitro and is currently evaluated as a potential
PET ligand for central nerve system imaging.
2. Methods
2.1. Animals. PET experiments were performed using 10
male Wistar rats (274±24 g; Harlan Netherlands B.V., Horst,
The Netherlands), who were kept in conditioned housing
under a regular light/dark cycle (12/12 h), allowing food and
water ad libitum. All animal experiments were performed
in compliance with Dutch laws and were approved by
the University Animal Ethics Committee (VU University
Amsterdam, The Netherlands).
2.2. Tracer Synthesis. [18F]NaF was prepared by passing an
[18F]fluoride solution in water over a Waters quaternary
methyl ammonium (QMA) light anion exchange cartridge
(Waters Chromatography B.V., Etten-Leur, The Nether-
lands), followed by elution from the QMA cartridge with
1mL 1.4% (w/v) of NaHCO3 in sterile H2O. This solu-
tion was collected in 10mL of saline containing 7.09mM
NaH2PO4. Subsequently, the whole mixture was passed over
a sterileMillex GV 0.22 µmfilter (Millipore B.V., Amsterdam,
The Netherlands), yielding a sterile and pyrogen-free solu-
tion with radiochemical purity >99.9% and a pH of 7.
Quality control of the [18F]NaF solution was performed
using an analytical high-performance liquid chromatogra-
phy (HPLC) system consisting of a Jasco PU-2080 HPLC
pump (Jasco, Ishikawa-cho, Japan), a Rheodyne 7724I injec-
tor (IDEXHealth & Science,Wertheim-Mondfeld, Germany)
with a 20 µL loop, a Bio-Rad Aminex Fermentation Moni-
toring Column 150× 7.8mm (Bio-Rad, Hercules, CA, USA)
with a Jasco UV-2075 Plus UV detector (Jasco, Ishikawa-cho,
Japan) and a NaI radioactivity detector (Raytest, Strauben-
hardt, Germany). The purity of the product was determined
using this analytical HPLC system eluted with water contain-
ing 0.001M sulphuric acid at a flow rate of 0.8mL·min−1.
[11C]AF150(S) was prepared as described in [14]. Briefly,
[11C]AF150(S) was obtained via methylation of AF400 with
[11C]CH3I. An incorporation yield of 90% of [11C]CH3 was
achieved in a 5-minute reaction time at 60◦C in CH3CN.
The product was purified by HPLC, recovered by solid
phase extraction and subsequently passed over a sterile
Millex GV 0.22 µm filter, yielding an isotonic, sterile, and
pyrogen-free solution. The final solution of [11C]AF150(S)
was obtained with a decay corrected overall yield of 69±12%
(n = 26), corresponding to 3200–7000MBq at the end of
the synthesis (i.e., 50 ± 5min). Radiochemical purity was
>99%, and specific activity at the end of synthesis was 23–
118GBq·µmol−1.
2.3. PET Data Acquisition. PET measurements were per-
formed using an ECAT HRRT (CTI/Siemens, Knoxville,
TN, USA). The ECAT HRRT is a dedicated human brain
PET scanner, with design features that enable high spatial
resolution combined with high sensitivity, making it also
suitable for small animal imaging. This scanner has a
transaxial field of view of 312mm and an axial field of view
of 250mm. The spatial resolution ranges from 2.3 to 3.2mm
full width at half maximum (FWHM) in transaxial direction
and from 2.5 to 3.4mm FWHM in axial direction [15].
First a transmission scan was performed using a 740MBq
2D fan-collimated 137Cs rotating point source. Following this
transmission scan, a 3D emission acquisition of 45min was
initiated immediately after an intravenous tail vein injection
of 9.9 ± 0.6MBq [11C]AF150(S). After the [11C]AF150(S)
scan, an intravenous dose of 14.2 ± 3.5MBq [18F]NaF was
administered, followed 30min later by a 3D emission of
30min. Acquired data were stored in 64-bit list mode format
and, for [11C]AF150(S), subsequently histogrammed into 21
time frames (7 × 10, 1 × 20, 2 × 30, 2 × 60, 2 × 150, and
7 × 300 s). [18F]NaF data were rebinned in a single frame of
30min. Data were reconstructed using 3D ordered subsets
weighted least squares (3D-OSWLS) [16] using 7 iterations
and 16 subsets. All data were normalized and corrected
for attenuation, randoms, scatter, decay, and dead-time. All
images were reconstructed into a matrix of 256 × 256 × 207
voxels with a voxel size of 1.218 × 1.218 × 1.218mm3.
2.4. MR Template. MR data were provided by the Image
Sciences Institute of the University Medical Center Utrecht
and consisted of a typical Wistar rat brain image, obtained
by averaging single MR images of 8 Wistar rat brains (mean
weight 305 g) acquired on a 4.7 Tesla MR system (Varian,
Palo Alto, CA, USA) using a 3D Fast Spin Echo sequence
(TR/TE = 1500/10ms, 128 × 128 × 128 voxels, 32 × 40 ×
32mm3). Final image dimensions were 144 × 112 × 152
voxels with voxel dimensions of 0.125 × 0.125 × 0.156mm3.
Voxel dimensions of the MR image were scaled to 0.1 ×
0.1 × 0.13mm3, as brain size did not correspond with that
in the present study. As an index of brain size, the distance
between left and right dorsal lateral sides of the tympanic
bulla was used. This distance was 14.4mm in the original
average MR image and 11.4 ± 0.1mm for rats used in the
present study (as was calculated from the [18F]NaF images).
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The MR template was generated by defining ROI on
this average MR image using AMIDE (version 0.9.1;
http://amide.sourceforge.net; [17]). ROI was defined from
the beginning of the striatum until the end of the
medulla oblongata, corresponding to plates 13 to 130 from
the Paxinos and Watson atlas of the rat brain [18].
2.5. MR Template Coregistration. Using AMIDE, the
[18F]NaF image of each individual animal was coregistered
manually with the MR template image by three diﬀerent
observers according to a predefined protocol. An overview
of the steps involved in this manual image coregistration is
depicted in Figure 1. Briefly, the centre of an [18F]NaF image
was moved until it roughly overlaid the MR template. Next,
rotational settings were adjusted until the [18F]NaF image
paralleled the MR template, and, finally, the centre was
adjusted again until the image fitted the MR template. MR
template and [18F]NaF image fits were considered successful
when (a) the medial surface of the cranial case was aligned
and the hemispheres were distributed ipsilaterally in a
coronal cross-section, (b) tympanic bullae and frontal bones
of the anterior part of the cranial cavity were aligned in a
transverse cross-section, and (c) the surface of the cranial
case and the articulation of parietal and occipital bones were
aligned in a sagittal cross-section, as illustrated in Figure 2.
Finally, dynamic [11C]AF150(S) data were coregistered by
directly applying the (rotational) settings obtained from the
corresponding [18F]NaF coregistration.
2.6. ROI Analysis. Validation of ROI analysis software was
performed on simulated data using AMIDE. ROI of the MR
template was projected onto two simulated PET images that
consisted of voxels with a theoretical content of either 0 or
1 kBq, arranged in a 3D checkerboard pattern. One image
had voxel dimensions equal to the MR image, whereas the
other had voxel dimensions equal to the PET image. Since
there is a considerable diﬀerence in spatial resolution with
a factor of 1390 diﬀerence in voxel volumes, the purpose of
this simulation was to check whether ROI volumes andmean
ROI activity were similar for both images.
For ROI analysis of experimental data, the MR template
was projected onto the coregistered [11C]AF150(S) images,
using the corresponding [18F]NaF image. The percentage
injected dose per gram tissue (%ID/g) was calculated for each
brain region using the following equation:
%
ID
g
= regional radioactivity concentration
(
kBq/mL
)
(
injected dose
(
kBq
)× density brain tissue (g/mL))
× 100%
(1)
in which a mean brain tissue density of 1.045 g/mL was used
[19].
2.7. Evaluation of Image Coregistration. Interobserver vari-
ability of the image coregistration method was investigated
Launch amide
until it is at the same level as the MR template
until it parallels the MR template
until it fits the MR template
Load MR template
in X , Y , Z directions
in X , Y , Z directions
Load [18F]NaF image of rat X
Adjustment of centre of [18F]NaF image
Adjustment of rotation of [18F]NaF image
Readjustment of centre of [18F]NaF image
Load [11C]AF150(S) image of rat X
in Z direction
Adjustment of centre and rotation of [11C]AF150(S) image
by application of the [18F]NaF transformation matrix
Figure 1: Overview of the various steps to manually coregister
[18F]NaF and [11C]AF150(S) images with the MR template.
by comparing results of the three independent observers
for all brain regions specified. The reproducibility of image
coregistration was assessed by considering the variability
within subjects not attributable to possible systematic dif-
ferences between observers. It was assumed that the within-
subject variability was the same for all subjects when there
were no statistically significant diﬀerences, and it was esti-
mated by calculating the standard deviation of the between-
observer diﬀerences recorded for each subject. Expressed as a
coeﬃcient of variation (COV), this standard deviation pro-
vides a dimensionless measure of reproducibility. Reliability
between the 3 observers was quantified using the intraclass
correlation coeﬃcient for absolute agreement (ICCA) and
consistency (ICCC). Validity of the image coregistration
method was verified comparing PET derived %ID/g data
with previously obtained measurements of %ID/g in ex vivo
biodistribution studies. Briefly, 5 groups of 4 of rats received
an intravenous injection of [11C]AF150(S) and were sacri-
ficed at 5, 10, 15, 30, or 60min after injection. Brains were
excised and regions dissected. All brain regions were weighed
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Figure 2: Example of an [18F]NaF image coregistered with MR image and the MR template. (I) [18F]NaF image, coregistered with (II) MR
image and (III) MR template for (a) coronal, (b) transverse, and (c) sagittal cross-sections. Arrows indicate (1) medial surface cranial case,
(2) ipsilateral line distributing hemispheres, (3) frontal bones, (4) tympanic bulla, (5) surface of cranial case, and (6) articulation of parietal
and occipital bones.
and counted for radioactivity using an automatic gamma
counter (Wallac 1282 CompugammaCS, LKBWallac, Turku,
Finland), and the %ID/g was calculated as percentage of total
radioactivity injected, divided by the weight of the tissue.
2.8. Statistics. All statistical analyses were performed using
SPSS Statistics (version 17.0; SPSS Inc., Chicago, IL, USA).
The Shapiro-Wilk test was used to confirm that all data were
normally distributed. A two-tailed paired Student’s t-test was
used for ROI analysis of the checkerboard simulation study.
The correlation between ROI results (ROI volume and mean
ROI activity concentration) of MR and PET checkerboard
images was assessed using squared Pearson’s correlation. A
two-way ANOVAwith Bonferroni posttest was used for com-
parison of%ID/gmeasures obtained by the various observers
Table 1: Regions and volumes of ROI defined on the MR template.
Brain region Volume (mm3)
Left striatum 16.4
Right striatum 15.1
Hippocampus 26.4
Frontal cortex (including part parietal cortex) 46.1
Posterior cortex (including occipital cortex) 49.6
Medulla oblongata (part) 15.7
Cerebellum 86.6
who delineated ROI for [11C]AF150(S) PET data and for
the comparison of PET and ex vivo derived %ID/g values.
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Table 2: Volume, mean activity concentration, and total activity in various ROIs projected onto the checkerboard images with MR and PET
resolution.
Brain region
MR image PET image
Volume
(mm3)
Mean voxel
Activity concentrationa
(kBq·mL−1)
Mean ROI
activity
(Bq)
Volume
(mm3)
Mean voxel
Activity concentrationb
(kBq·mL−1)
Mean ROI
activity
(Bq)
Left striatum 16.4 0.50 8.19 15.3 0.52 7.95
Right striatum 15.1 0.50 7.56 14.7 0.50 7.30
Hippocampus 26.4 0.50 13.22 26.8 0.50 13.38
Frontal cortex 46.1 0.50 23.03 48.6 0.50 24.13
Posterior cortex 49.6 0.50 24.80 48.9 0.49 23.96
Medulla oblongata 15.7 0.50 7.85 15.8 0.49 7.75
Cerebellum 86.7 0.50 43.35 86.0 0.49 42.14
a
1 MR voxel = 0.0013mm3.
b1 PET voxel = 1.81mm3.
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Figure 3: Pearson’s correlation plot of mean ROI activity for all brain regions in PET versus MR checkerboard.
The interobserver reliability for [11C]AF150(S) PET data
(mean ROI %ID/g) was computed by intraclass correlation
coeﬃcient using a two-way mixed eﬀects model for absolute
agreement (ICCA) and consistency (ICCC). ICC scores range
from 0 to 1, representing a level of agreement: ≤0.40 poor
to fair, 0.41–0.60 moderate, 0.61–0.80 substantial, 0.81–1.00
almost perfect [20]. Confidence intervals were also calculated
for each ICC score. Data are reported as mean ± SD, and
diﬀerences were considered significant at a level of P < 0.05.
3. Results
3.1. MR Template. Table 1 provides an overview of the ROI
defined on the MR image.
3.2. ROI Analysis. Both ROI volumes and mean ROI activity
concentrations in left and right striata, posterior cortex, and
medulla oblongata were slightly lower for the PET than for
the MR resolution checkerboard images. The opposite was
true for hippocampus, frontal cortex, and cerebellum, as
shown in Table 2. More importantly, both ROI volumes and
mean ROI activities derived fromMR and PET checkerboard
images were not significantly diﬀerent from each other.
Correlation analysis of mean ROI activity concentrations in
MR and PET resolution checkerboard images yielded a slope
of 0.982, an intercept of 0.173, and an R2 of 0.998 (Figure 3).
3.3. Evaluation of Image Coregistration. Figure 4 shows a
typical example of a coregistered MR image and template
with PET images. Quantitative reproducibility of image
coregistration was assessed using [11C]AF150(S) data by
comparing %ID/g data between observers at five diﬀerent
time points (Table 3). The Shapiro-Wilk test confirmed that
these data were consistent with the normal distribution (W
statistic ≥ 0.936, P ≥ 0.511). The comparison of %ID/g data
revealed that for each time point none of the observations
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Figure 4: Overview of coregistered MR image and template with PET images. (I) MR image, (II) MR template, (III) [18F]NaF image, and
(IV) [11C]AF150(S) image (0–45min) for (a) coronal, (b) transverse, and (c) sagittal cross-sections.
were significantly diﬀerent from each other (P > 0.722).
In addition, COV values were not significantly diﬀerent
between the 3 observers (P > 0.467).
Interobserver reliability of the image coregistration
method was assessed by calculating ICCA and ICCC of
mean uptake in each region, as derived by the 3 observers.
These results are summarized in Table 4 and, for all regions,
show almost perfect agreement (ICCA > 0.856) between
observers. In addition, for all regions, there was almost
perfect consistency (ICCC > 0.939) between observers.
Observed regional brain uptake of [11C]AF150(S) was
compared between PET and ex vivo studies. The Shapiro-
Wilk test (W statistic ≥ 0.885, P ≥ 0.361) confirmed that
these data were consistent with the normal distribution.
International Journal of Molecular Imaging 7
Table 3: [11C]AF150(S) uptake (%ID/g) derived from various brain regions by three observers following image coregistration.
Number of subjects (n = 10)
Region
Left striatum Right striatum Hippocampus Frontal cortex Posterior cortex Medulla oblongata Cerebellum Mean COV
Observer 1
5min 1.06± 0.16 1.04± 0.17 0.98± 0.16 0.95± 0.13 0.92± 0.14 0.67± 0.13 0.80± 0.14 16.12
10min 0.70± 0.11 0.71± 0.11 0.67± 0.10 0.64± 0.11 0.64± 0.10 0.46± 0.08 0.53± 0.08 16.08
15min 0.57± 0.09 0.57± 0.10 0.54± 0.09 0.52± 0.08 0.52± 0.08 0.38± 0.06 0.44± 0.07 15.96
30min 0.33± 0.05 0.33± 0.05 0.32± 0.05 0.30± 0.05 0.31± 0.05 0.25± 0.04 0.27± 0.05 15.81
45min 0.23± 0.04 0.23± 0.05 0.23± 0.04 0.21± 0.04 0.22± 0.04 0.18± 0.04 0.20± 0.04 18.49
Observer 2
5min 1.05± 0.17 1.05± 0.18 0.99± 0.16 0.99± 0.17 0.95± 0.17 0.66± 0.12 0.80± 0.14 17.26
10min 0.70± 0.12 0.72± 0.12 0.68± 0.11 0.67± 0.13 0.65± 0.12 0.47± 0.08 0.53± 0.09 17.19
15min 0.57± 0.10 0.58± 0.10 0.55± 0.09 0.54± 0.10 0.53± 0.09 0.39± 0.06 0.44± 0.08 17.10
30min 0.33± 0.05 0.33± 0.05 0.33± 0.05 0.31± 0.05 0.31± 0.05 0.24± 0.04 0.28± 0.05 16.67
45min 0.23± 0.04 0.24± 0.04 0.23± 0.04 0.22± 0.04 0.22± 0.04 0.18± 0.03 0.20± 0.04 18.08
Observer 3
5min 1.06± 0.16 1.04± 0.17 0.98± 0.15 0.93± 0.14 0.89± 0.14 0.71± 0.14 0.80± 0.14 16.44
10min 0.70± 0.12 0.71± 0.12 0.67± 0.11 0.64± 0.11 0.61± 0.10 0.48± 0.07 0.53± 0.09 16.52
15min 0.56± 0.09 0.57± 0.10 0.54± 0.09 0.51± 0.08 0.50± 0.08 0.40± 0.06 0.44± 0.07 16.51
30min 0.32± 0.06 0.33± 0.05 0.32± 0.05 0.30± 0.05 0.29± 0.05 0.25± 0.04 0.28± 0.05 16.70
45min 0.22± 0.04 0.23± 0.04 0.23± 0.04 0.21± 0.04 0.21± 0.04 0.19± 0.04 0.20± 0.04 18.86
Data represent mean± SD (n = 10).
Table 4: Intraclass correlation coeﬃcients and corresponding 95% confidence intervals for regional [11C]AF150(S) brain uptake (%ID/g).
Number of subjects (n = 10)
ROI
Observer 1 versus 2 Observer 1 versus 3
ICCA 95% CL ICCC 95% CL ICCA 95% CL ICCC 95% CL
Left striatum 0.998 (0.991, 0.999) 0.997 (0.990, 0.999) 0.997 (0.988, 0.999) 0.997 (0.988, 0.999)
Right striatum 0.995 (0.978, 0.999) 0.995 (0.981, 0.999) 0.998 (0.991, 0.999) 0.998 (0.992, 0.999)
Hippocampus 0.997 (0.989, 0.999) 0.997 (0.989, 0.999) 0.992 (0.769, 0.999) 0.997 (0.989, 0.999)
Frontal cortex 0.930 (0.491, 0.985) 0.961 (0.853, 0.990) 0.985 (0.886, 0.997) 0.991 (0.963, 0.998)
Posterior cortex 0.956 (0.826, 0.989) 0.962 (0.856, 0.990) 0.927 (0.102, 0.987) 0.978 (0.913, 0.994)
Medulla oblongata 0.966 (0.879, 0.991) 0.967 (0.873, 0.992) 0.904 (−0.022, 0.984) 0.985 (0.940, 0.996)
Cerebellum 0.993 (0.972, 0.998) 0.992 (0.969, 0.998) 0.970 (0.499, 0.994) 0.988 (0.954, 0.999)
Observer 2 versus 3 Overall
Left striatum 0.997 (0.988, 0.999) 0.997 (0.989, 0.999) 0.997 (0.992, 0.999) 0.997 (0.992, 0.999)
Right striatum 0.998 (0.991, 0.999) 0.997 (0.990, 0.999) 0.997 (0.990, 0.999) 0.997 (0.991, 0.999)
Hippocampus 0.987 (0.632, 0.998) 0.996 (0.983, 0.999) 0.992 (0.947, 0.998) 0.997 (0.991, 0.999)
Frontal cortex 0.907 (0.080, 0.983) 0.968 (0.878, 0.992) 0.937 (0.682, 0.985) 0.972 (0.922, 0.992)
Posterior cortex 0.856 (0.062, 0.971) 0.939 (0.776, 0.985) 0.911 (0.605, 0.979) 0.959 (0.885, 0.989)
Medulla oblongata 0.895 (0.306, 0.977) 0.945 (0.794, 0.986) 0.919 (0.608, 0.981) 0.966 (0.904, 0.991)
Cerebellum 0.957 (0.663, 0.991) 0.977 (0.910, 0.994) 0.974 (0.881, 0.994) 0.986 (0.960, 0.996)
Level of agreement: ≤0.40 poor to fair, 0.41–0.60 moderate, 0.61–0.80 substantial, 0.81–1.00 almost perfect.
A graphical overview for the various time points is given in
Figure 5, indicating no significant diﬀerences between both
datasets at any of the time points, except for cerebellum at
5min and hippocampus at 10min.
4. Discussion
4.1. Data Acquisition. The proposed generic method for
ROI analysis of PET data acquired in rats is based on the
acquisition of an additional [18F]NaF scan. In the present
study, the additional acquisition time was 30min, starting
30min after injection of ∼14MBq of [18F]NaF. This time
frame, however, can be adapted according to experimental
design in future studies.
4.2. ROI Analysis. In order to determine eﬀects of diﬀerent
spatial resolutions (1390 MR voxels correspond with one
PET voxel) on ROI analyses, calculation of average ROI
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Figure 5: Uptake (%ID/g) of [11C]AF150(S) in various brain regions obtained from PET and ex vivo biodistribution experiments. PET
studies, dark gray (n = 10, average of 3 observers), and ex vivo biodistribution experiments, light gray (n = 4 per time point). Data are
presented as mean± SD. Level of significance was evaluated using a two-way ANOVA with Bonferroni posttest; ∗P < 0.05.
values and volumes was validated using a simulated checker-
board scan. In general, less than 7% diﬀerence in volumes
and less than 5% in mean ROI activity values were observed
between PET images with PET and MR resolution (Table 2)
and none of these diﬀerences were significant. In addition,
mean ROI activity values derived from both images showed
near perfect correlation (R2 > 0.998; slope = 0.982). There-
fore, applying MR-based ROI onto PET images is repro-
ducible with respect to both ROI volumes and mean ROI
activity values.
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4.3. Evaluation of the Image Coregistration Paradigm. All
three observers successfully coregistered all ten [18F]NaF
images with the MR brain template, following the procedure
as outlined in Figure 1. Derived uptake of [11C]AF150(S) was
not significantly diﬀerent between observers for any brain
region and any time point. Following image coregistration
of [11C]AF150(S) scans, interobserver agreement (ICCA and
ICCC) of uptake was excellent for all brain regions. This
implies that the image coregistration procedure is very reli-
able. Moreover, uptake values were similar to those obtained
from an ex vivo study. The minor diﬀerences at 10min for
hippocampus and at 5min for cerebellum might be ascribed
to individual variability in combination with the relatively
small groups of animals. Interestingly, both PET and ex vivo
biodistribution results indicate that [11C]AF150(S) uptake is
highest in striatum, followed by hippocampus, then cortex
and then cerebellum, closely following the distribution of
M1ACh-R in rat brain [21].
Clearly, some user-dependent uncertainty may remain
in the coregistration of MR template and [18F]NaF images.
Based on the good interobserver correspondence in the
manual procedure, semiautomatic or fully automatic image
coregistration methods could be investigated for easier and
faster ROI analysis of small animal PET studies.
Although several methods are available for PET coreg-
istration in small animals [5–7, 9, 10], reproducibility was
not assessed for all those methods. In two previous small
animal studies reproducibility of brain uptake has been
investigated [8, 22] using direct ROI definition on PET
images or predefined PET templates for [11C]raclopride
scans. Reproducibility of [11C]raclopride uptake was found
to be between 10% and 22%. These values are similar to
the reproducibility of [11C]AF150(S) uptake observed in the
present study (average COV of 17%), suggesting that there is
no additional uncertainty due to application of the presently
described two-step method of ROI analysis. The advantage
of the present method is that it allows exact localization of
the brain, independent of radioligand and PET scanner used,
and without the need to perform an individual MR scan for
each rat.
In the near future, multimodality imaging may provide
better means for analysis of small animal PET studies. The
presently available combined PET/CT small animal scanners
do have certain notable shortcomings, that is, the inability
to perform simultaneous data acquisition and lesser contrast
among soft tissues compared to MR. Nevertheless, the CT
component of PET/CT images may be used to coregister
these images with MR. Ultimately, the emerging role of
hybrid PET/MR small animal imaging may provide better
means for tracer-independent data analysis of rat brain
studies and should be further investigated.
5. Conclusions
Reproducible analysis of PET data is possible using coreg-
istration of an MR-based ROI template with an addi-
tional [18F]NaF scan. This method can serve as a reliable
and reproducible two-step method for tracer-independent
data analysis of rat brain studies, as demonstrated for
[11C]AF150(S) data.
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